focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Operations Update

27 Sep 2013 07:00

RNS Number : 0573P
Phorm Corporation Limited
27 September 2013

27 September 2013

Phorm Corporation Limited ("Phorm" or the "Company")

Operations Update

Revenue and Key Performance Indicators Show Strong Growth

Phorm (AIM: PHRM), a leading internet personalization technology company, announces today that it is seeing strong sustained growth in revenue and other key performance indicators.

3.6 million monthly opted-in users

1.2 million active on daily basis, 100% increase from June

Advertising network and publisher partners provide over 1.2 billion requests per month

Over 66 million advertising impressions served in August

Advertising products demonstrating excellent performance

Increasing evidence of market-leading conversion rates

Phorm previously announced on 28 June that it had reached commercial scale in Turkey such that it was delivering advertising campaigns and that revenue generation had commenced. Despite market activity being at seasonal lows, considerable commercial traction has been achieved over recent months and the Company has seen considerable growth in revenues and other Key Performance Indicators including user numbers, advertising requests and advertising impressions served. In addition, Phorm has received very exciting feedback from its customers, with respect to conversion rates, which demonstrates that its platform has the ability to compete effectively in text advertising.

Phorm is pleased to announce that the number of daily active users is now 1.2 million, a 100% increase on the number previously announced on 28 June and the rate of growth is increasing. Phorm has now conclusively demonstrated the viability of an opt-in model and is pleased that it continues to lead the market in terms of consumer choice and protection.

Phorm has continued to sign and build its publisher network. In June, the Company announced that it was receiving an average of 30 million requests per day, this has now grown to over 40 million requests per day. In August the Company received a total of over 1.2 billion advertising requests.

The number of advertising impressions served by the Company is also continuing to grow. In June the Company served 39 million, this has grown by over 70% to 67 million by the end of August. Phorm is able to serve both display and text advertising, which allows advertisers to target advertising at the key-word level without using a search engine.

Phorm is also delighted to announce that it has received some excellent feedback from its advertising partners with respect to conversion rates. Conversion is key to ensuring the long-term success of the platform as it is the measure of the proportion of clicks that result in the user action desired by the advertiser; for example to buy a product or fill in an application form. Phorm has demonstrated across a range of sectors and campaigns that its targeted advertising can result in very high conversion rates. In recent campaigns, Phorm has achieved conversion rates of up to 40%.

The Company is now focused on building its revenue based on these excellent results and will update the market further in due course.

-ends-

Contact

Phorm Corporation Limited

Andy Croxson (analysts & investors) +44 207 297 2067

Liberum Capital +44 20 3100 2222 (Nominated Advisor and Joint Broker)

Chris Bowman

Richard Bootle

Mirabaud Securities LLP +44 20 7321 2508 (Joint Broker)

Jason Woollard

Peter Krens

About Phorm

Phorm is a global personalization technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

Phorm's industry leading technology enables its ISP partners to offer a new type of online advertising platform and a free consumer internet content feature, ensuring more relevant advertisements and personalized content for opted-in users.

Phorm's advertising platform revolutionizes current standards of online privacy, fully protecting the identity of consumers. Unlike virtually all other targeted advertising propositions, Phorm's solution is completely opt-in. Only those users consenting to the service are profiled and only ever on an anonymous basis.

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Advertising Networks and Advertisers.

Phorm, under a predecessor holding company, was admitted to the AIM market of the London Stock Exchange in 2004.

For more information, please visit: www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTLLFSDAFIRFIV
Date   Source Headline
19th Jun 20127:00 amRNSAGM Statement
1st Jun 20127:00 amRNS£20m equity fundraising into Phorm China
1st Jun 20127:00 amRNSIntention to Re-Domicile
22nd May 20127:00 amRNSPhorm Announces AGM Notice & Proposed Board Change
21st Mar 20127:00 amRNSAppointment of Nominated Adviser and Joint Broker
5th Mar 20127:00 amRNSTransfer of Shares
1st Mar 20127:00 amRNSTransfer of Shares
28th Dec 20117:00 amRNSDirector Dealing
12th Dec 201110:10 amRNSTransfer of Shares
7th Dec 201110:19 amRNSTransfer of Shares
2nd Dec 20112:02 pmRNSTR-1: Notification of Major Interest in Shares
2nd Dec 201112:16 pmRNSTransfer of Shares
11th Nov 20117:30 amRNSIssue of Equity
4th Nov 20117:30 amRNSIssue of Equity
21st Oct 20113:28 pmRNSIssue of Equity
20th Oct 20114:14 pmRNSTransfer of Shares
7th Oct 20112:00 pmRNSBlock Admission Return
30th Sep 20117:00 amRNSInterim Results for Six Months Ended 30 June 2011
28th Sep 20117:00 amRNSProduct Launch
30th Jun 20117:00 amRNSAnnual Financial Report
8th Apr 201112:00 pmRNSBlock Admission Return
30th Mar 20117:00 amRNSTR-1: Notification of Major Interest in Shares
22nd Mar 20117:00 amRNSPlacing and operating update
2nd Mar 201112:00 pmRNSTransfer of Shares
1st Feb 201110:14 amRNSResult of AGM
6th Jan 20117:15 amRNSOption Grant and Modification
6th Jan 20117:05 amRNSAdvisory Board Appointment - Juan Villalonga
24th Dec 20108:11 amRNSNotice of AGM
17th Dec 20109:11 amRNSIssue of convertible secured loan notes
8th Oct 20105:25 pmRNSBlock Admission Return
30th Sep 20107:00 amRNSInterim results
22nd Sep 20107:00 amRNSUpdate on Commercial Deployment in Brazil
17th Aug 20103:42 pmRNSCorrection re Share Transfer
16th Aug 20103:58 pmRNSShare Transfer
16th Aug 20108:50 amRNSDirectorate Change
30th Jul 20101:00 pmRNSTransfer of Shares
23rd Jul 201011:17 amRNSDirectorate Change
16th Jul 20104:25 pmRNSTransfer of Shares
9th Jul 20107:00 amRNSTransfer of Shares
7th Jul 20104:55 pmRNSDirector/PDMR Shareholding
7th Jul 20102:19 pmRNSPlacing of Shares
30th Jun 20102:17 pmRNSAnnual Report & Accounts Notification
30th Jun 20107:00 amRNSPreliminary Results
28th Jun 20107:00 amRNSNotification of results
8th Jun 20102:05 pmRNSChange in name of Nominated Adviser
30th Apr 20101:08 pmRNSGrant of options
9th Apr 20105:25 pmRNSBlock Admission Return
26th Mar 20107:00 amRNSCommercial Deployment in Brazil
28th Jan 20104:37 pmRNSNotification of Major Interest in Shares
11th Jan 20104:28 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.